Main menu

NCM 2022: Identification of *Leishmania infantum* epidemiological, drug resistance and pathogenicity biomarkers

  • Leishmania infantum is a protist parasite and causative agent of leishmaniasis, endemic to many countries world-wide, per example the Mediterranean basin.
  • Emerging drug-resistant L. infantum is one of the most relevant neglected tropical disease, as it is responsible for 12M infections w/w and more than 25,000 deaths.
  • It possesses a genome of 32 Mb distributed in 36 chromosomes and a complex network of maxi- and minicircle kinetoplasts (functionally similar to mitochondria).
  • Its genome is structurally complex, with frequent rearrangements and aneuploidies. Such changes in copy number variation (CNV) occur as a result of environment adaptation and can be potentially used as genetic biomarkers to create a genetic resistance profile.

Download the PDF

入門

MinION Starter Packを購入 ナノポア製品の販売 シークエンスサービスプロバイダー グローバルディストリビューター

お問い合わせ

Intellectual property Cookie policy Corporate reporting Privacy policy Terms, conditions and policies Accessibility

Oxford Nanoporeについて

Contact us 経営陣 メディアリソース & お問い合わせ先 投資家向け Oxford Nanopore社で働く BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust
Japanese flag